ResearcherNingxia Medical UniversityNo recent work listed

Libin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7861-1560; OpenAlex author ID A5100662925. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.3233/cbm-181182 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongqiang Hua · 1 shared paper, 2018 · strength 0.08
- Paper LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ducta… DOI 10.3233/cbm-181182 ↗
Zhen Chen · 1 shared paper, 2018 · strength 0.08
- Paper LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ducta… DOI 10.3233/cbm-181182 ↗
Zhiqiang Meng · 1 shared paper, 2018 · strength 0.08
- Paper LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ducta… DOI 10.3233/cbm-181182 ↗
Liya Huang · 1 shared paper, 2018 · strength 0.08
- Paper LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ducta… DOI 10.3233/cbm-181182 ↗
Feng Wang · 1 shared paper, 2018 · strength 0.08
- Paper LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ducta… DOI 10.3233/cbm-181182 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.